These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5565858)

  • 1. Sexual behavior during L-dopa treatment for Parkinsonism.
    Bowers MB; Van Woert M; Davis L
    Am J Psychiatry; 1971 Jun; 127(12):1691-3. PubMed ID: 5565858
    [No Abstract]   [Full Text] [Related]  

  • 2. The activating effect of L-dopa treatment on sexual functions and its experimental background.
    Hyyppä M; Rinne UK; Sonninen V
    Acta Neurol Scand; 1970; 46(S43):223-4. PubMed ID: 5466273
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of L-dopa on testosterone and luteinizing hormone production.
    Sinhamahapatra SB; Kirschner MA
    J Clin Endocrinol Metab; 1972 Apr; 34(4):756-8. PubMed ID: 5012777
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-dopa in the treatment of Parkinsonism].
    Domzal T; Pakszys W
    Wiad Lek; 1972 Aug; 25(15):1391-5. PubMed ID: 5073625
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of l-dopa in man.
    Goodwin FK
    Semin Psychiatry; 1971 Nov; 3(4):477-92. PubMed ID: 5173049
    [No Abstract]   [Full Text] [Related]  

  • 6. L-dopa and the negative symptoms of Parkinsonism.
    Klawans HL; Erlich M
    J Neurol Neurosurg Psychiatry; 1969 Oct; 32(5):460-1. PubMed ID: 5360053
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical electroencephalographic studies during the treatment of parkinsonism with an L-DOPA preparation].
    Krasnov EA; Romenskaia LKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):520-3. PubMed ID: 4705406
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinsonism, L-dopa, and intelligence.
    Loranger AW; Goodell H; McDowell FH; Lee JE; Sweet RD
    Am J Psychiatry; 1973 Dec; 130(12):1386-9. PubMed ID: 4754685
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of L-dopa on electromyograph and heart rate of parkinsonians.
    De Vito AJ; Riklan M; Misiak H
    Percept Mot Skills; 1972 Feb; 34(1):51-4. PubMed ID: 5011849
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of L(-)-dopa on baroreflexes in Parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
    Wälzholz U; Schönfelder H
    Nervenarzt; 1972 Oct; 43(10):531-2. PubMed ID: 4628192
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-dopa on the H-reflex in parkinsonism.
    Fujita S; Cooper IS
    J Am Geriatr Soc; 1971 Apr; 19(4):289-95. PubMed ID: 4936279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
    Sato G; Ito H; Handa Y; Takahashi I; Iijima K
    No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa].
    Bergamini L; Bonzanino A; Bignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1970 Feb; 91(1):10-6. PubMed ID: 5524931
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract]   [Full Text] [Related]  

  • 16. L-dopa effects on motor and "central programming" deficits in Parkinsonism.
    Horne DJ
    Psychopharmacologia; 1974 Apr; 36(2):175-80. PubMed ID: 4407693
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of L-dopa on the EEG and EMG in Parkinson patients.
    Visser SL; Postma JU
    Psychiatr Neurol Neurochir; 1971; 74(4):315-21. PubMed ID: 5146237
    [No Abstract]   [Full Text] [Related]  

  • 18. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of L-dopa on seborrhoea of parkinsonism.
    Burton JL; Shuster S
    Lancet; 1970 Jul; 2(7662):19-20. PubMed ID: 4193751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of parkinsonism with L-dopa].
    Hernández Peniche J; Martínez Villar C; De León Charles C
    Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.